AU6378796A - Ranitidine salts on magnesium trisilicate as an adsorbate - Google Patents

Ranitidine salts on magnesium trisilicate as an adsorbate

Info

Publication number
AU6378796A
AU6378796A AU63787/96A AU6378796A AU6378796A AU 6378796 A AU6378796 A AU 6378796A AU 63787/96 A AU63787/96 A AU 63787/96A AU 6378796 A AU6378796 A AU 6378796A AU 6378796 A AU6378796 A AU 6378796A
Authority
AU
Australia
Prior art keywords
adsorbate
magnesium trisilicate
ranitidine
salts
ranitidine salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63787/96A
Inventor
John Denick
Anthony B Eoga
Albert F. Sorg
Kirti H. Valia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU6378796A publication Critical patent/AU6378796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU63787/96A 1995-06-06 1996-06-05 Ranitidine salts on magnesium trisilicate as an adsorbate Abandoned AU6378796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US468216 1983-02-22
US46821695A 1995-06-06 1995-06-06
PCT/US1996/008978 WO1996039126A2 (en) 1995-06-06 1996-06-05 Ranitidine salts on magnesium trisilicate as an adsorbate

Publications (1)

Publication Number Publication Date
AU6378796A true AU6378796A (en) 1996-12-24

Family

ID=23858888

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63787/96A Abandoned AU6378796A (en) 1995-06-06 1996-06-05 Ranitidine salts on magnesium trisilicate as an adsorbate

Country Status (2)

Country Link
AU (1) AU6378796A (en)
WO (1) WO1996039126A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
EA006777B1 (en) 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Pharmaceutical compositions of adsorbates of amorphous drug
WO2005023225A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Cilostazol adsorbate
EP2072042A1 (en) * 2007-12-21 2009-06-24 Lek Pharmaceuticals D.D. Active pharmaceutical ingredient on solid support, amorphous and with improved solubility
EP2238979A1 (en) * 2009-04-06 2010-10-13 LEK Pharmaceuticals d.d. Active pharmaceutical ingredient adsorbed on solid support

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IT1251153B (en) * 1991-08-06 1995-05-04 Vectorpharma Int SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION HAVING PROHIBITED GASTRIC RESIDENCE

Also Published As

Publication number Publication date
WO1996039126A2 (en) 1996-12-12
WO1996039126A3 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
AU5647094A (en) Pyrrolo-pyridine derivatives
AU6849896A (en) Universal mount for rifle
AU4875396A (en) Benzoyl derivatives
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU7253796A (en) Novel substituted naphthopyrans
AU7626994A (en) Engine control
AU4086296A (en) Indolepiperidine derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU697028B2 (en) N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics
AU6929796A (en) Benzoyl derivatives
AU5080596A (en) Chromone derivatives
AU6571594A (en) Thioindole pyperidinyl derivatives used as antalgics
AU7634896A (en) Substituted porphyrins
AU6378796A (en) Ranitidine salts on magnesium trisilicate as an adsorbate
AU3343295A (en) Imidazopyridine salt
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU6994396A (en) Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU4547396A (en) Thioquinoline derivatives
AU6309396A (en) Novel use for pyrrole derivatives
AU6737996A (en) Boronic acid derivatives
AU3709593A (en) N-methyldeacetylcolchiceinamide derivatives
AU4220096A (en) 4-mercaptobenzoylguanidine derivatives